HU181725B - Process for producing immunotherapeutic pharmaceutical composition - Google Patents

Process for producing immunotherapeutic pharmaceutical composition Download PDF

Info

Publication number
HU181725B
HU181725B HU801726A HU172680A HU181725B HU 181725 B HU181725 B HU 181725B HU 801726 A HU801726 A HU 801726A HU 172680 A HU172680 A HU 172680A HU 181725 B HU181725 B HU 181725B
Authority
HU
Hungary
Prior art keywords
nctc
strains
lysate
cultured
sodium
Prior art date
Application number
HU801726A
Other languages
German (de)
English (en)
Hungarian (hu)
Inventor
Jean-Claude Farine
Anne Rivkine
Isidro Bultro
Original Assignee
Om Lab Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Om Lab Sa filed Critical Om Lab Sa
Publication of HU181725B publication Critical patent/HU181725B/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
HU801726A 1979-07-26 1980-07-10 Process for producing immunotherapeutic pharmaceutical composition HU181725B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH692479A CH639852A5 (fr) 1979-07-26 1979-07-26 Medicament contre les maladies infectieuses des voies urinaires et digestives.

Publications (1)

Publication Number Publication Date
HU181725B true HU181725B (en) 1983-11-28

Family

ID=4317195

Family Applications (1)

Application Number Title Priority Date Filing Date
HU801726A HU181725B (en) 1979-07-26 1980-07-10 Process for producing immunotherapeutic pharmaceutical composition

Country Status (16)

Country Link
JP (1) JPS5622733A (fr)
AR (1) AR222887A1 (fr)
BE (1) BE884456A (fr)
CH (1) CH639852A5 (fr)
CS (1) CS212234B2 (fr)
DD (1) DD153192A5 (fr)
DE (1) DE3019448A1 (fr)
ES (1) ES8104402A1 (fr)
FR (1) FR2462164A1 (fr)
GB (1) GB2054374B (fr)
HU (1) HU181725B (fr)
IT (1) IT1143025B (fr)
PL (1) PL127520B1 (fr)
PT (1) PT71612A (fr)
RO (1) RO80054A (fr)
YU (1) YU42532B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2550707B1 (fr) * 1983-08-17 1986-02-28 Lipha Medicament immunomodulateur d'origine biologique et son procede de preparation
US4740585A (en) * 1984-07-30 1988-04-26 The Board Of Trustees Of The Leland Stanford Junior University Synthetic vaccine against urinary infections
WO2004112833A1 (fr) 2003-06-23 2004-12-29 Biotech Tools Sa Composition d'epitope pour administration par voie sublinguale, buccale ou enterale, obtenue par hydrolyse de structures antigeniques a l'aide de chymotrypsine
BRPI0808351A2 (pt) * 2007-03-05 2014-07-29 Om Pharma Extrato bacteriano para doenças do trato digestivo ou urinário e proesso para sua preparação.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1336015A (en) * 1970-06-03 1973-11-07 Unilever Ltd Rearing pigs
BE789864A (fr) * 1971-10-14 1973-04-09 Unilever Nv Elevage des veaux
US3911109A (en) * 1971-10-14 1975-10-07 Lever Brothers Ltd Rearing calves
JPS5219927B2 (fr) * 1972-06-08 1977-05-31
GB1462384A (en) * 1973-04-12 1977-01-26 Unilever Ltd Rearing of lambs
GB1560934A (en) * 1975-05-07 1980-02-13 Unilever Ltd Methods for the resistance of non-human mammals to gastro-intestinal disorders
US4141970A (en) * 1975-05-07 1979-02-27 Internationale Octrooimaatschappij "Octropa" B.V. Method for enhancing the resistance of new born mammalian young to gastro-intestinal infections
US4136167A (en) * 1975-06-12 1979-01-23 Internationale Octrooi Maatschappij "Octropa" B.V. Process for reducing the incidence of neonatal diarrhoea in pigs
GB1581776A (en) * 1976-08-18 1980-12-17 Smith Kline Rit Vaccines against oedema disease of piglets

Also Published As

Publication number Publication date
PT71612A (fr) 1980-08-01
RO80054A (fr) 1982-10-26
JPH0255407B2 (fr) 1990-11-27
AR222887A1 (es) 1981-06-30
FR2462164B1 (fr) 1983-08-05
GB2054374A (en) 1981-02-18
YU42532B (en) 1988-10-31
IT8049314A0 (it) 1980-07-24
FR2462164A1 (fr) 1981-02-13
CS212234B2 (en) 1982-03-26
YU189680A (en) 1983-06-30
PL127520B1 (en) 1983-11-30
DD153192A5 (de) 1981-12-30
ES491920A0 (es) 1981-04-01
CH639852A5 (fr) 1983-12-15
JPS5622733A (en) 1981-03-03
IT1143025B (it) 1986-10-22
DE3019448A1 (de) 1981-02-12
DE3019448C2 (fr) 1987-07-30
PL225853A1 (fr) 1981-05-08
BE884456A (fr) 1980-11-17
GB2054374B (en) 1983-06-22
ES8104402A1 (es) 1981-04-01

Similar Documents

Publication Publication Date Title
CA1246445A (fr) Agent ameliorant la flore intentinale
JP3653277B2 (ja) ラクトバチルス菌株、該菌株の組成物および該菌株の使用法
CH653556A5 (de) Arzneimittel mit antitumor-wirkung.
EP0555618A2 (fr) Compositions diététiques ou pharmaceutiques comprenant des bactéries lactiques lyophilisées, leurs préparation et usage
US20130309212A1 (en) Lactobacillus salivarius and method for preparing metabolite thereof, composition of lactobacillus salivarius and metabolite thereof and use of the composition
EP0228861A2 (fr) Agent pour reduire le niveau de dimethylnitrosoamine
CN117106679A (zh) 一种缓解胰岛素抵抗的益生菌剂及其应用
US4451457A (en) Cyclodextrin and method for promoting the proliferation of intestinal bifidobacteria
US4343784A (en) Composition and method employing extracts of Hansenula as a medicament
CN114774315A (zh) 鼠李糖乳杆菌菌株LRa05在制备增强免疫力制品和/或缓解湿疹制品方面的用途
WO2019051790A1 (fr) Megamonas funiformis et ses applications
HU181725B (en) Process for producing immunotherapeutic pharmaceutical composition
CN117143783A (zh) 一种唾液联合乳杆菌vb330及其应用
KR0169982B1 (ko) 피부염 치료용 약제
WO2019109348A1 (fr) Utilisation de butyribacter intestini dans la prévention et/ou le traitement de maladies liées à l'inflammation
CN110062806B (zh) 粪厌氧棒杆菌(Anaerostipes caccae)及其应用
JPS61271223A (ja) 血中脂質改善剤
JP2969017B2 (ja) 感染防御剤
CN101410409A (zh) 免疫调节组合物
WO2019051789A1 (fr) Anaerofustis stercorihominis et ses applications
EP0196858B1 (fr) Agent d'amélioration de la fonction du foie et agent pour abaisser la tension sanguine
WO2018107364A1 (fr) Collinsella shenzhenensis et ses applications
JP3273948B2 (ja) 生理活性物質ｔｋｒ１７８５類、製造方法及び微生物
JPS6069022A (ja) 免疫調整剤及びその製造法
TWI754929B (zh) 乳酸菌用於提升對腸病毒７１型之抵抗力之用途

Legal Events

Date Code Title Description
HU90 Patent valid on 900628